Literature DB >> 27793995

Identifying Patients at Risk for Prehospital Sudden Cardiac Arrest at the Early Phase of Myocardial Infarction: The e-MUST Study (Evaluation en Médecine d'Urgence des Stratégies Thérapeutiques des infarctus du myocarde).

Nicole Karam1, Sophie Bataille2, Eloi Marijon2, Olivier Giovannetti2, Muriel Tafflet2, Dominique Savary2, Hakim Benamer2, Christophe Caussin2, Philippe Garot2, Jean-Michel Juliard2, Virginie Pires2, Thévy Boche2, François Dupas2, Gaelle Le Bail2, Lionel Lamhaut2, François Laborne2, Hugues Lefort2, Mireille Mapouata2, Frederic Lapostolle2, Christian Spaulding2, Jean-Philippe Empana2, Xavier Jouven2, Yves Lambert2.   

Abstract

BACKGROUND: In-hospital mortality of ST-segment-elevation myocardial infarction (STEMI) has decreased drastically. In contrast, prehospital mortality from sudden cardiac arrest (SCA) remains high and difficult to reduce. Identification of the patients with STEMI at higher risk for prehospital SCA could facilitate rapid triage and intervention in the field.
METHODS: Using a prospective, population-based study evaluating all patients with STEMI managed by emergency medical services in the greater Paris area (11.7 million inhabitants) between 2006 and 2010, we identified characteristics associated with an increased risk of prehospital SCA and used these variables to build an SCA prediction score, which we validated internally and externally.
RESULTS: In the overall STEMI population (n=8112; median age, 60 years; 78% male), SCA occurred in 452 patients (5.6%). In multivariate analysis, younger age, absence of obesity, absence of diabetes mellitus, shortness of breath, and a short delay between pain onset and call to emergency medical services were the main predictors of SCA. A score built from these variables predicted SCA, with the risk increasing 2-fold in patients with a score between 10 and 19, 4-fold in those with a score between 20 and 29, and >18-fold in patients with a score ≥30 compared with those with scores <10. The SCA rate was 28.9% in patients with a score ≥30 compared with 1.6% in patients with a score ≤9 (P for trend <0.001). The area under the curve values were 0.7033 in the internal validation sample and 0.6031 in the external validation sample. Sensitivity and specificity varied between 96.9% and 10.5% for scores ≥10 and between 18.0% and 97.6% for scores ≥30, with scores between 20 and 29 achieving the best sensitivity and specificity (65.4% and 62.6%, respectively).
CONCLUSIONS: At the early phase of STEMI, the risk of prehospital SCA can be determined through a simple score of 5 routinely assessed predictors. This score might help optimize the dispatching and management of patients with STEMI by emergency medical services.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; death, sudden, cardiac; myocardial infarction; prognosis

Mesh:

Year:  2016        PMID: 27793995     DOI: 10.1161/CIRCULATIONAHA.116.022954

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

Review 1.  New Concepts in Sudden Cardiac Arrest to Address an Intractable Epidemic: JACC State-of-the-Art Review.

Authors:  Sanjiv M Narayan; Paul J Wang; James P Daubert
Journal:  J Am Coll Cardiol       Date:  2019-01-08       Impact factor: 24.094

2.  Is near-time prevention for sudden cardiac arrest feasible? The e-MUST score.

Authors:  Nicole Karam; Sophie Bataille; Eloi Marijon; Muriel Tafflet; Frederic Lapostolle; Christian Spaulding; Xavier Jouven; Yves Lambert
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

3.  We must identify patients at risk for pre-hospital sudden cardiac arrest at the early phase of myocardial infarction.

Authors:  Santiago Montero; Alain Combes; Matthieu Schmidt
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  Patient-reported symptoms improve prediction of acute coronary syndrome in the emergency department.

Authors:  Jessica K Zègre-Hemsey; Larisa A Burke; Holli A DeVon
Journal:  Res Nurs Health       Date:  2018-08-31       Impact factor: 2.228

Review 5.  Electroimmunology and cardiac arrhythmia.

Authors:  Jana Grune; Masahiro Yamazoe; Matthias Nahrendorf
Journal:  Nat Rev Cardiol       Date:  2021-03-02       Impact factor: 32.419

Review 6.  Modifier genes for sudden cardiac death.

Authors:  Peter J Schwartz; Lia Crotti; Alfred L George
Journal:  Eur Heart J       Date:  2018-11-21       Impact factor: 35.855

7.  The MEDEA FAR-EAST Study: Conceptual framework, methods and first findings of a multicenter cross-sectional observational study.

Authors:  Sophia Hoschar; Jiangqi Pan; Zhen Wang; Xiaoyan Fang; Xian'e Tang; Weiqi Shi; Rongxiang Tu; Peng Xi; Wenliang Che; Hongbao Wang; Yawei Li; Kurt Fritzsche; Xuebo Liu; Karl-Heinz Ladwig; Wenlin Ma
Journal:  BMC Emerg Med       Date:  2019-05-02

8.  Amiodarone Treatment in the Early Phase of Acute Myocardial Infarction Protects Against Ventricular Fibrillation in a Porcine Model.

Authors:  Stefan M Sattler; Anniek F Lubberding; Lasse Skibsbye; Reza Jabbari; Reza Wakili; Thomas Jespersen; Jacob Tfelt-Hansen
Journal:  J Cardiovasc Transl Res       Date:  2019-01-07       Impact factor: 4.132

Review 9.  Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models.

Authors:  Stefan Michael Sattler; Lasse Skibsbye; Dominik Linz; Anniek Frederike Lubberding; Jacob Tfelt-Hansen; Thomas Jespersen
Journal:  Front Cardiovasc Med       Date:  2019-11-05

10.  Ivabradine is as effective as metoprolol in the prevention of ventricular arrhythmias in acute non-reperfused myocardial infarction in the rat.

Authors:  Mariusz Marciszek; Aleksandra Paterek; Marta Oknińska; Urszula Mackiewicz; Michał Mączewski
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.